相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy: Basic Principles and Relevance to Transplant Immunity
P. Bizargity et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Adenosine Triphosphate-Competitive mTOR Inhibitors: A New Class of Immunosuppressive Agents That Inhibit Allograft Rejection
B. R. Rosborough et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
The Second-Generation mTOR Kinase Inhibitor INK128 Exhibits Anti-inflammatory Activity in Lipopolysaccharide-Activated RAW 264.7 Cells
Hao Pan et al.
INFLAMMATION (2014)
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
Alexey Berezhnoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Complement as a multifaceted modulator of kidney transplant injury
Paolo Cravedi et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2
Chen Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway
Giovanni Stallone et al.
KIDNEY INTERNATIONAL (2014)
PKCβII acts downstream of chemoattractant receptors and mTORC2 to regulate cAMP production and myosin II activity in neutrophils
Lunhua Liu et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex
Emily B. Heikamp et al.
NATURE IMMUNOLOGY (2014)
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Antoine Marais et al.
NATURE IMMUNOLOGY (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Rictor Is Required for Early B Cell Development in Bone Marrow
Yingchi Zhang et al.
PLOS ONE (2014)
Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs
Sharad Shrestha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity
Shih-Chin Cheng et al.
SCIENCE (2014)
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies
Laure-Emmanuelle Croze et al.
TRANSPLANT INTERNATIONAL (2014)
Rapamycin Augments Human DC IL-12p70 and IL-27 Secretion to Promote Allogeneic Type1 Polarization Modulated by NK Cells
C. Macedo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Plasmacytoid Dendritic Cells: No Longer an Enigma and Now Key to Transplant Tolerance?
N. M. Rogers et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
The ULK1 complex Sensing nutrient signals for autophagy activation
Pui-Mun Wong et al.
AUTOPHAGY (2013)
Rheb and Rags come together at the lysosome to activate mTORC1
Marlous J. Groenewoud et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Requirement for Rictor in homeostasis and function of mature B lymphoid cells
Keunwook Lee et al.
BLOOD (2013)
Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions
P. P. C. Boor et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
Venus Thomanetz et al.
JOURNAL OF CELL BIOLOGY (2013)
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells
Chen Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Critical Role of the Tumor Suppressor Tuberous Sclerosis Complex 1 in Dendritic Cell Activation of CD4 T Cells by Promoting MHC Class II Expression via IRF4 and CIITA
Hongjie Pan et al.
JOURNAL OF IMMUNOLOGY (2013)
Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeleton
Yuan He et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
Greg M. Delgoffe et al.
NATURE (2013)
mTORC1 couples immune signals and metabolic programming to establish Treg-cell function
Hu Zeng et al.
NATURE (2013)
The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus
Rachael Keating et al.
NATURE IMMUNOLOGY (2013)
Abrogation of Chronic Rejection in Rat Model System Involves Modulation of the mTORC1 and mTORC2 Pathways
Li Zhang et al.
TRANSPLANTATION (2013)
B-cell-mediated strategies to flight chronic allograft rejection
Ali Dalloul
FRONTIERS IN IMMUNOLOGY (2013)
A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody
T. Hirohashi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Vascular Smooth Muscle Cell Apoptosis Promotes Transplant Arteriosclerosis Through Inducing the Production of SDF-1α
J. Li et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Regulation of Immune Responses by mTOR
Jonathan D. Powell et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α
Alison M. McInturff et al.
BLOOD (2012)
Metabolic switching and fuel choice during T-cell differentiation and memory development
Gerritje J. W. van der Windt et al.
IMMUNOLOGICAL REVIEWS (2012)
Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia
Keunwook Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cutting Edge: mTORC1 in Intestinal CD11c+CD11b+ Dendritic Cells Regulates Intestinal Homeostasis by Promoting IL-10 Production
Masashi Ohtani et al.
JOURNAL OF IMMUNOLOGY (2012)
Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
Eyal Amiel et al.
JOURNAL OF IMMUNOLOGY (2012)
Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients
Bjoern Nashan et al.
TRANSPLANTATION (2012)
Akt and mTOR in B cell activation and differentiation
Jose J. Limon et al.
FRONTIERS IN IMMUNOLOGY (2012)
Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation
Camila Macedo et al.
TRANSPLANTATION RESEARCH (2012)
Rapamycin-Induced Enhancement of Vaccine Efficacy in Mice
Chinnaswamy Jagannath et al.
MTOR: METHODS AND PROTOCOLS (2012)
Paradoxical Aspects of Rapamycin Immunobiology in Transplantation
I. R. Ferrer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production
Shuling Zhang et al.
BLOOD (2011)
Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells
Thomas Weichhart et al.
BLOOD (2011)
Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation and loss of marginal zone B cells
Sandrine Benhamron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
mTOR Inhibitors in Advanced Renal Cell Carcinoma
Martin H. Voss et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Mammalian Target of Rapamycin Complex 2 (mTORC2) Negatively Regulates Toll-like Receptor 4-mediated Inflammatory Response via FoxO1
Jonathan Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
Seth A. Wander et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy
S. Brouard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
H. Tedesco Silva et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS
Heth R. Turnquist et al.
BLOOD (2010)
Mammalian Target of Rapamycin Controls Dendritic Cell Development Downstream of Flt3 Ligand Signaling
Taheri Sathaliyawala et al.
IMMUNITY (2010)
Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways
Keunwook Lee et al.
IMMUNITY (2010)
ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish
Bin Ren et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cutting Edge: Rapamycin Augments Pathogen-Specific but Not Graft-Reactive CD8+ T Cell Responses
Ivana R. Ferrer et al.
JOURNAL OF IMMUNOLOGY (2010)
A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation
Michael Haidinger et al.
JOURNAL OF IMMUNOLOGY (2010)
Sin1-mTORC2 Suppresses rag and il7r Gene Expression through Akt2 in B Cells
Adam S. Lazorchak et al.
MOLECULAR CELL (2010)
Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection
Abdelhamid Liacini et al.
TRANSPLANTATION (2010)
Comparative Analysis of Adverse Events Requiring Suspension of mTOR Inhibitors: Everolimus versus Sirolimus
A. I. Sanchez-Fructuoso et al.
TRANSPLANTATION PROCEEDINGS (2010)
Pneumonitis Associated With Mammalian Target of Rapamycin Inhibitors in Renal Transplant Recipients: A Single-Center Experience
P. Errasti et al.
TRANSPLANTATION PROCEEDINGS (2010)
Targeting mTOR globally in cancer Thinking beyond rapamycin
Boris Shor et al.
CELL CYCLE (2009)
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Greg M. Delgoffe et al.
IMMUNITY (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Immunoregulatory functions of mTOR inhibition
Angus W. Thomson et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells
Masashi Ohtani et al.
BLOOD (2008)
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart et al.
IMMUNITY (2008)
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Sokol Haxhinasto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR
Johnthomas Kang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway
Weiping Cao et al.
NATURE IMMUNOLOGY (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
Endothelial Cells in Allograft Rejection
Rafia S. Al-Lamki et al.
TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells
W. Gao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice
Yanyan Qu et al.
TRANSPLANT IMMUNOLOGY (2007)
Selective survival of naturally occurring human CD4(+)CD25(+)Foxp3(+) regulatory T cells cultured with rapamycin
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2007)
Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4(+) T cells, but enrich for antigen-specific Foxp3(+) T regulatory cells and promote organ transplant tolerance
Heth R. Turnquist et al.
JOURNAL OF IMMUNOLOGY (2007)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo
H Hackstein et al.
BLOOD (2003)
Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries
P Religa et al.
TRANSPLANTATION (2002)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
分享论文
